跳至主要内容
临床试验/CTRI/2025/10/096355
CTRI/2025/10/096355尚未招募不适用

To determine if the dimensions of patients’ self-efficacy influence the treatment outcomes of yoga and allied therapies.

Patanjali Research Foundation Trust1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年11月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
1. Self-efficacy questionnaire

研究概览

简要总结

The objective of the study is to  assess the effect of patients self efficacy on treatment outcomes in various spectrum of diseases in an integrated therapy center in north India.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients who will be visiting integrated therapy center for their treatment.

排除标准

  • Patients who will return incomplete questionnaires or will not complete 7 days of treatment.

结局指标

主要结局

1. Self-efficacy questionnaire

时间窗: 1. Self-efficacy questionnaire will be assessed at baseline (i.e., at day 0) | 2. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 3. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 4. The Global Perceived Effect Scale will be assessed at day 7.

2. EQ-5D-5L

时间窗: 1. Self-efficacy questionnaire will be assessed at baseline (i.e., at day 0) | 2. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 3. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 4. The Global Perceived Effect Scale will be assessed at day 7.

3. Physical Health Questionnaire

时间窗: 1. Self-efficacy questionnaire will be assessed at baseline (i.e., at day 0) | 2. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 3. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 4. The Global Perceived Effect Scale will be assessed at day 7.

4. The Global Perceived Effect Scale

时间窗: 1. Self-efficacy questionnaire will be assessed at baseline (i.e., at day 0) | 2. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 3. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment | 4. The Global Perceived Effect Scale will be assessed at day 7.

次要结局

未报告次要终点

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Shirley Telles

Patanjali Research Foundation (Trust)

研究点 (1)

Loading locations...

相似试验